Clin2
NCT07017959Possibly a fitNot yet recruiting

Probiotic supplement for gut health in inflammatory bowel disease

Inflammatory Bowel Diseases

Part of Digestive system clinical trials.

This study tests whether a daily probiotic supplement (a beneficial bacteria) can improve the protective lining of the gut and reduce leakage in people with inflammatory bowel disease (IBD). It involves taking the supplement for a period of time and undergoing some measurements of gut health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with IBD for more than 3 months and have had a colonoscopy within the last 2 years.
  • Your IBD symptoms are mild to moderate.
  • Your body mass index (BMI) is between 18 and 40, and you have not had a dramatic weight change (more than 20 pounds) in the past 2 weeks.
  • You are willing to stop taking any other probiotics, prebiotics, or fermented foods (like yogurt, kefir, kombucha) for at least 30 days before and during the study.
  • You have not had antibiotics, diarrhea, or vomiting in the last 30 days, and you do not have certain health conditions like severe heart, kidney, or immune system problems, cancer, or uncontrolled diabetes.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06342011Recruiting
Anti-inflammatory diet for inflammatory bowel disease

This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.

Yiwu, Zhejiang
NCT07799428Not yet recruiting
Probiotic supplement for inflammatory bowel disease

This trial tests whether a probiotic supplement can help manage symptoms of inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. You may be eligible if you are an adult with IBD and can take the supplement for at least 14 days.

Hà Nội
NCT07533890Recruiting
Probiotics and gut health in children with inflammatory bowel disease

This study tests whether a multi-strain probiotic supplement can change the gut bacteria in children and teens with inflammatory bowel disease (IBD). Researchers will collect stool samples to see if the probiotics help restore healthy gut bacteria and potentially improve symptoms.

Bern
NCT06781827Recruiting
Probiotics for newly diagnosed IBD

This study tests whether taking probiotics can help prevent or treat inflammatory bowel disease (IBD) in people recently diagnosed. It aims to see if friendly bacteria can calm gut inflammation and improve symptoms.

Suqian, Jiangsu
NCT07047339Recruiting· Phase 2/Phase 3
Probiotic 6600 for colitis patients

This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.

Shanghai
NCT07724990Recruiting
Probiotic for gut health in mild-to-moderate colitis

This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.

Roma, RM

Hear when a new Inflammatory Bowel Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.